Tag Archives: cancer

Help fund HOPE: Support the American Cancer Society

Will you join me in providing much-needed financial support to help fight back against cancer?

the quick version: I’m raising funds to help support American Cancer Society research, programs and services. Can you help this effort with a donation?

Have more time? Keep reading to learn more and donate!

Help fund hope

Your donation to the American Cancer Society helps to fund hope.

The American Cancer Society is at the forefront of the battle against cancer.

In 2022 alone, the American Cancer Society invested $267 million in groundbreaking cancer research. These funds support innovative studies aimed at discovering better treatments, understanding the causes of cancer and improving the quality of life for those affected by the disease. This research is crucial for making strides in prevention, early detection, and treatment of cancer.

The American Cancer Society has funded numerous groundbreaking research projects over the past 50 years that have significantly advanced our understanding and treatment of cancer.

Here are five crucial research projects:

Discovery of the BRCA1 and BRCA2 genes

In the 1990s, American Cancer Society-funded researchers played a pivotal role in identifying the BRCA1 and BRCA2 genes, mutations of which are linked to a higher risk of breast and ovarian cancers.

This discovery has led to the development of genetic tests that can identify individuals at high risk, allowing for preventive measures such as increased surveillance, prophylactic surgeries, and personalized treatment plans.

Development of the HPV vaccine

American Cancer Society-funded research was instrumental in the development of the human papillomavirus (HPV) vaccine, which protects against the virus responsible for the majority of cervical cancer cases.

The introduction of the HPV vaccine has the potential to drastically reduce the incidence of cervical and other HPV-related cancers, offering a powerful tool for cancer prevention.

Advances in chemotherapy for childhood leukemia

The American Cancer Society has supported numerous studies that have improved chemotherapy protocols for treating childhood leukemia, particularly acute lymphoblastic leukemia, or “ALL.”

These advancements have significantly increased survival rates for children diagnosed with ALL, transforming it from a largely fatal disease to one with a high cure rate.

Research on immunotherapy

The American Cancer Society has funded pioneering research in immunotherapy, which harnesses the body’s immune system to fight cancer. This includes work on checkpoint inhibitors and CAR T-cell therapy.

Immunotherapy has revolutionized cancer treatment, offering new hope for patients with types of cancer that were previously difficult to treat, such as melanoma and certain types of lymphoma.

Understanding cancer metastasis

American Cancer Society-funded researchers have made significant strides in understanding how cancer spreads (metastasizes) from its original site to other parts of the body.

This research has led to the development of treatments aimed at preventing metastasis, which is responsible for the majority of cancer deaths. By targeting metastatic processes, these treatments have the potential to improve survival rates and quality of life for patients.

Value of the research

  • Patients: These projects have led to earlier detection, more effective treatments, and higher survival rates, offering hope and improved outcomes for patients.
  • Caregivers: Advancements in cancer treatment and understanding help caregivers by providing them with better tools and knowledge to support their loved ones through their cancer journey.
  • Cancer community: Continued research fosters a deeper understanding of cancer biology, paving the way for innovative therapies and ultimately bringing us closer to a world without cancer.

These contributions by the American Cancer Society underscore the critical role of research in transforming cancer care and improving the lives of patients and their families.

Cancer incidences on the rise as cancer deaths decline

The American Cancer Society expects the U.S. to hit a bleak milestone: More than 2 million new cases of cancer. That’s almost 5,500 per day.

Some cancer types are increasing in specific subgroups. For example, colorectal cancer is rising among people under 55, liver cancer in women, oral cancers linked to HPV and cervical cancer in women aged 30-44.

While four of these cancers (breast, prostate, colorectal and cervical) have screening tests, which can prevent cancer by detecting precancerous lesions, the incidence of six rising cancers is associated with excess body weight: Endometrial, liver, kidney, pancreatic, colorectal and breast cancers.

The rising incidence of cancer affects younger populations as well. Although people aged 65 and older still represent a significant proportion of cancer diagnoses, this group’s share has decreased from 61% in 1995 to 58% in 2019-2020.

Conversely, cancer diagnoses in people aged 50-64 are increasing. This shift is partly due to declines in prostate and smoking-related cancers in older men and rising cancer incidence in those born since the 1950s, potentially linked to the obesity epidemic and other unknown factors.

The proportion of people under 50 diagnosed with cancer has decreased from 15% to 12%, despite an overall rise in cancer incidence in this age group from 1995 to 2020.

Colorectal cancer is notably increasing among those under 50, now the leading cause of cancer death in younger men and the second in women.

The cause remains unclear but may involve lifestyle changes since the 1950s. Cervical cancer is also rising in women aged 30-44, while it has declined in women aged 20-24 who were among the first to receive the HPV vaccine.

Over the past 30 years, the cancer death rate in the United States has steadily declined, saving approximately 4 million lives.

This decrease is attributed to significant progress in smoking cessation, early detection and treatment advancements.

However, the incidence of many common cancers is rising. In 2024, the US is expected to see new cancer cases surpass 2 million, equating to about 5,500 diagnoses daily.

This increase is driven by an aging population and a rise in six of the ten most common cancers: breast, prostate, endometrial, pancreatic, kidney and melanoma.

Projected cancer deaths for 2024 are over 611,000, with more than 1,600 deaths daily.

LGBTQ people face unique risks for developing cancer

LGBTQ people face unique cancer risks and significant disparities in cancer incidence and outcomes. Research indicates disparities across the cancer continuum—from prevention to early detection and treatment—though more data is needed to fully understand these differences.

“The LGBTQ+ population has some differences in exposures that are probably pretty influential in terms of their risk for developing cancer, but we can’t look at the cancer risk because we don’t have data. Data is also key for the development of targeted cancer-control efforts. It’s time the US fills that gap,” said Rebecca Siegel, one of the authors of the 2024 “Cancer Facts & Figures” study.

Currently, population-based information on cancer in the LGBTQ+ community is limited to national surveys that gather data on risk factors and screening practices. However, there are no active methods for collecting comprehensive data on cancer incidence and mortality in this group because sexual orientation and gender identity are not consistently recorded in medical records. This lack of data hampers targeted cancer control efforts and underscores the need for more inclusive data collection practices to address and mitigate these disparities effectively.

Cancer increasingly affecting younger people

Cancer is increasingly affecting younger populations. While cancer risk typically rises with age, the demographics of cancer diagnoses are shifting. In 1995, people aged 65 and older accounted for 61% of new cancer cases, but by 2019-2020, this had dropped to 58%. Meanwhile, the proportion of cancer diagnoses in those aged 50 to 64 has grown, driven by declines in prostate cancer and smoking-related cancers among older men, and a rise in cancers in those born since the 1950s, likely influenced by the obesity epidemic and other unknown factors.

Conversely, the proportion of cancer diagnoses in individuals under 50 has decreased from 15% to 12%, although this group saw an overall increase in cancer incidence from 1995 to 2020. A significant concern is the rise in colorectal cancer among those under 50, now the leading cause of cancer death in men under 50 and the second in women of the same age. This increase is likely due to lifestyle changes starting with those born around 1950. Nearly one-third of individuals diagnosed with colorectal cancer before 50 have a family history or genetic predisposition, prompting recommendations for earlier screening.

Additionally, cervical cancer rates are rising among women aged 30 to 44. In contrast, the HPV vaccine’s impact is evident in women aged 20-24, with a notable decline in cervical cancer incidence from 2012 to 2019.

Progress against cancer lags in communities of color

Racial disparities in cancer remain significant and persistent. Black individuals with prostate, stomach and uterine cancers have double the death rate compared to white individuals. Similarly, American Indian and Alaska Native individuals face twice the death rates for liver, stomach and kidney cancers compared to white people.

Key statistics highlight these disparities:

  • Black men have the highest overall cancer death rate, 19% higher than white men, primarily due to prostate cancer.
  • American Indian and Alaska Native people have the highest overall incidence and mortality rates for men and women combined. Alaska Natives have the highest global rates of colorectal cancer incidence and mortality.
  • Hispanic individuals have lower rates of common cancers like breast and prostate but high rates of infection-related cancers, with cervical cancer incidence 35% higher than in white women.
  • Black women with endometrial cancer face double the death rate of white women, despite similar incidence, due to later diagnoses and poorer survival rates.

Advancements in cancer treatment and early detection have not benefited minority communities equally. Historical and ongoing racial discrimination has led to significant socioeconomic disparities, limiting access to healthy living conditions, timely cancer diagnoses and high-quality treatment. Segregationist and discriminatory policies in various sectors continue to exacerbate these inequalities, impacting cancer outcomes in these populations.

So, what can you do? What can WE do?

With YOUR support, the American Cancer Society is making a difference in the fight against cancer through research grants that help to uncover better ways to treat cancer, find cancer and help people with cancer live better lives.

With YOUR support, the American Cancer Society is helping to fund programs and services that provide support to cancer patients, their families and, really, all of us.

Among these programs is the organization’s 24/7 cancer support line, which offers a live human available any hour of the day to answer any questions you might have about cancer. You can call 1-800-227-2345.

See you Saturday in Erie!

Visit the American Cancer Society Relay For Life of Erie County between 11 a.m. and 5 p.m. June 22 at Iroquois Jr./Sr. High School, along Iroquois Avenue in Lawrence Park.

See the event schedule!

WHY I RELAY…

For nearly 30 years, I’ve been a participant, supporter and volunteer with the American Cancer Society. What began as a way to celebrate and remember the life of my grandmother has grown to celebrate, remember and honor far too many other people who have been impacted by cancer. I Relay to help fund hope.

Your support will help fund research, programs, services, information — and it will help fund hope.

Nuts about health: Let’s talk testicular cancer awareness

April marks Testicular Cancer Awareness Month, a crucial time to shed light on this often overlooked but highly treatable form of cancer.

Testicular cancer may not be as commonly discussed as other types of cancer, but it’s essential to raise awareness about the importance of early detection and screening. With knowledge and proactive measures, we can save lives and support those affected by this disease.

According to the American Cancer Society, about 9,760 new cases of testicular cancer will be diagnosed this year. It is the most common cancer diagnosed in young men 15 to 35. This underscores the importance of raising awareness among this demographic and encouraging regular screenings.

Early detection is key to successful treatment and improved outcomes for testicular cancer. The American Cancer Society recommends that men be aware of the signs and symptoms of testicular cancer, including:

  1. A lump or swelling in either testicle
  2. Pain or discomfort in the testicle or scrotum
  3. A feeling of heaviness in the scrotum
  4. Changes in the size or shape of the testicle
  5. A dull ache or sharp pain in the lower abdomen or groin

Regular self-exams can help men become familiar with the normal size, shape, and texture of their testicles, making it easier to detect any abnormalities. To perform a self-exam, men should gently roll each testicle between their thumb and fingers, checking for lumps, swelling, or other changes. Any concerns should be promptly discussed with a healthcare provider.

In addition to self-exams, routine screenings by a healthcare professional are essential for early detection. Men should speak with their doctors about their risk factors for testicular cancer and discuss the appropriate screening schedule based on their age, family history, and other factors.

For those facing a diagnosis of testicular cancer, it’s crucial to know that support and resources are available. Organizations like the American Cancer Society offer a wealth of information, guidance and support services for individuals and families affected by cancer. Their website provides comprehensive resources on testicular cancer, including information about treatment options, coping strategies and support groups.

For more information and resources on testicular cancer, visit the American Cancer Society’s website.

What if we could provide a targeted, non-invasive treatment for breast cancer?

Sounds incredible, right?

I’m participating in the Race To Beat Women’s Cancers 5K, which supports women’s cancer research and patient care at Magee-Womens Research Institute & Foundation, to help support research to find better treatments and reach a day when cures are possible.

Please consider making a donation to join this effort to fund research.

It is estimated that more than 927,000 women will be diagnosed with cancer in 2021. More than 281,000 women will be diagnosed with breast cancer. These numbers are staggering.

Add to these numbers are the women who are going through treatment or have ended treatment and are still dealing with the effects or surgeries related to having been diagnosed with cancer.

Researchers in Pittsburgh are making tremendous strides in the detection, treatment and prevention of women’s cancers — including breakthrough therapies for breast, ovarian and cervical cancers that are in large-scale clinical trials right now.


Research is changing the way breast cancer is treated.


And, with your support, the research at the Magee-Womens Research Institute & Foundation can go further.

By focusing on women’s health, the health of all people here in Pittsburgh and around the world can be improved.

What are Magee scientists doing right now?

  • Uncovering new prevention and treatment approaches in more than 20 clinical trials.
  • Working to solve for treatment resistance in the most common form of breast cancer.
  • Examining the vulnerabilities in triple negative breast cancer to find a more effective cure for this aggressive disease.

For more than two decades, Magee-Womens has dedicated clinical research studies and clinical trials to improving the health care of people everywhere — with research done right here in Pittsburgh.


One in eight women will be diagnosed with breast cancer in her lifetime.


Magee-Womens Research Institute collaborates with the UPMC Hillman Cancer Center to help reduce the incidence of and death from women’s cancers by supporting research aimed at translating novel discoveries into improved patient care.

This great work can continue to impact lives here in Western Pennsylvania and around the world — with your support.

Thank you for taking the time to read this and for supporting the important research and patient care at Magee-Womens.

Food trucks, cancer, 20 years, skipping Sheetz … oh my!

This year marks the 20th year since my grandma died. In fact, it was this past Sunday. A lot has happened in that time, but my devotion to giving another grandma more time with her grandson — time that I didn’t have with my own — continues. And, of course, many other people.

And, in the 20 years since her death, many other friends and loved ones have been diagnosed with cancer, and some have died.

Your support helps to fund research (some of which is happening in Pittsburgh — I talked with two American Cancer Society funded researchers in June who did their work at the University of Pittsburgh) and programs offered to cancer patients and families.

mission_06So, how can you help?

You can make donation of $20 (or whatever you’d like to/are able to give) to fund American Cancer Society cancer research and programs. And I can talk your ear off about the invaluable programs and research.

Relay For Life is my chance to celebrate loved ones who have won and are winning their battle against cancer, remember those no longer with us and fight back against this disease that robs so many of so much.
mission_02More than just walking the track, I’m fundraising! Because of YOUR donations, more people:

  • Have the information and tools they need to help reduce their risk of getting cancer or find the disease early, when it’s easiest to treat
  • Have a place to turn for help 24/7
  • Benefit from the progress being made toward finding cancer’s causes and cures
  • Get access to lifesaving screenings and treatment

Please join me in fighting cancer and consider supporting my fundraising efforts by making a donation.

And what am I doing to help?

Truth be told, I’ve not been as successful this year at fundraising. So, I’ve decided to skip buying anything from Sheetz (unless if I need gas) this week and donating to my Relay For Life efforts the money I’d have spent otherwise.

And, if you know me or follow me on social media, you know I practically live at Sheetz.

So my goal is to not spend any money on food/drink items at Sheetz from July 18 through 8 a.m. July 23.

You’re probably like, “OK, but that’s maybe 10 bucks.” And you’d be wrong. There are days when I’m at Sheetz three or four times per day. Now, it’s not always for lunch, but it all adds up.

So I’ve decided I’m going to take my last seven Sheetz receipts, add them up and donate that money. If my math is correct, I’ll donate about $80.

What about the FOOD TRUCKS, though? YOU SAID THERE WOULD BE FOOD TRUCKS.

So this Saturday (July 23) — during the Relay For Life of Greater Cranberry Township — is a FOOD TRUCK DINNER PARTY. It’s from 5-8 p.m. at North Boundary Park in Cranberry. SEVEN of the Pittsburgh food trucks will be there! Some of the proceeds benefit the event!

Amission_01nd while you’re there … be sure to check out the American Cancer Society Relay For Life of Greater Cranberry Township events going on, too! Here’s a full schedule. There are a lot of events for kids, plus there are bands performing and all sorts of activities.

Can’t make the food truck dinner party or RFLCranberry? Or, can make it and still want to support research efforts and programs? Please consider a making a $15, $20 or whatever you’d like to offer donation. You can do so here.

Thank you so much for your support. Together, we will finish the fight!

hope